Area of research
Molecular Biology · Materials Chemistry
Research interest
Research interests include Protein Kinase Regulation and GTPase Signaling, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, and ATP Synthase and ATPases Research.
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.